AKCA - Akcea Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AKCA (1662524)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
5 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-07-15
AKCABoyce SarahPresS - Sale$23.52-1,81919,888-8%-$42,783
DM
2019-04-05
AKCAGoldberg Jeff MarcCOOS - Sale+OE$31.71-50,0002,880-95%-$1,585,718
DM
2019-04-05
AKCASoteropoulos PaulaCEOS - Sale+OE$32.11-31,7870-100%-$1,020,780
D
2019-03-06
AKCASoteropoulos PaulaCEOS - Sale+OE$32.14-18,3860-100%-$590,856
2018-04-17
AKCAIonis Pharmaceuticals Inc10%P - Purchase$18.75+10,666,66664,114,545+20%+$199,999,988
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top